Back close

In vitro studies on pharmacological potential of mycoendophyte of Simarouba glauca

Start Date: Friday, Jan 01,2016

End Date: Tuesday, May 31,2016

In vitro studies on pharmacological potential of mycoendophyte of Simarouba glauca

The exploration of endophytes is still an emerging field. Almost all plants seem to deliver endophytes with promising contents and activities. Simarouba glauca has a long history in herbal medicine as antiparasitic, antidysentric, antipyretic and anti cancerous agent in many countries. Recently the plant extract has received much attention in India as an anti cancer and anti arthritic medicine.  In the present study endophytic fungi from Simarouba glauca were isolated and evaluated for their pharmacological properties. SG-S, an endophytic fungus isolated in our study was found to exhibit anti bacterial, anti oxidant and anti hyper glycaemic potential. Qualitative phyto chemical analysis of the crude extract of SG-S showed presence of flavanoids, triterpenes, alkaloids and carbohydrates, many of them being  reported to have bio active properties. Further research is needed to characterize the isolate and purify the compounds. Thus the medicinal plant S.glauca could be a great source material for isolation of endophytes with bioactive metabolites.

Related Projects

The Role of Rural Institutions in Enabling Adaptation to Climate Change in the Agricultural Sector across Different Ecosystems in India
The Role of Rural Institutions in Enabling Adaptation to Climate Change in the Agricultural Sector across Different Ecosystems in India
Biocompatible Antenna for Wearable Health Care Application
Biocompatible Antenna for Wearable Health Care Application
WE: Rural Toilet Builder-Community Sanitation ph2
WE: Rural Toilet Builder-Community Sanitation ph2
Multi-Layer Intelligence for Disaster Information Dissemination for Maritime Network
Multi-Layer Intelligence for Disaster Information Dissemination for Maritime Network
Paraptosis: a Newer Approach to Target Cancer
Paraptosis: a Newer Approach to Target Cancer
Admissions Apply Now